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ABSTRACT 
Macrolide and tetracycline antibiotics are drugs used for treatment and prevention 
of infectional illnesses both in human and veterinary medicine. As other environmental 
contaminats, they can accumulate in environment and induce adverse effects 
in terrestrial and aquatic organisms. and induce bacterial resistance. The sensitive 
analytical methods are necessary to quantify their level in wastewaters to rate the risk 
caused by their presence in environment. 
 
The HPLC with MS detection is method mostly used to analysis, because of its high 
sensitivity. A method using UV or fluorescence detection was tried to be developed 
as an alternative to HPLC-MS. 
 
A method to analyse macrolide using Hichrom Lichrosorb RP 18, 250 x 4.6 mm i. d. 
and Chromolith Performance column RP 18e, 100 x 4.6 mm i. d. were used. A mobile 
phase ACN: 0.05M KH2PO4 (pH 7.5) 30:70 (v/v) was used, the detector was set 
at 215 nm. 
The method using pre-column derivatization by FMOC-Cl was studied. The analysis 
was performed on Chromolith Performance column RP 18e, 100 x 4.6 mm i. d. 
The fluorescence detector was set at excitation wavelength 255 nm and emission 
wavelength 315 nm. 
 
The method to analyse tetracyclines used gradient elution of ACN and 0.02 M oxalic 
acid. The analysis was performed on Hichrom Lichrosorb RP 8, 250 x 4.6 mm i. d. 
column. The detector was set at 360 nm. 
 
All the method tested did not show good results and are not suitable to wastewater 
analysis 
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ABSTRAKT 
Tetracyklinová a makrolidová antibiotika jsou léčiva užívaná k léčbě infečních 
onemocnění jak v humánní, tak veterinární medicině.Podobně jako jiné látky 
znečišťující životní prostředí, mohou v prostředí přetrvávat a indukovat negativní 
účinky v pozemních i vodních organismech a indukovat vznik bakteriální rezistence. 
Citlivé analytické metody jsou nezbytné k jejich stanovení v odpadních vodách 
k odhadu rizika plynoucího z jejich výskytu v životním prostředí. 
 
Kvůli vysoké citlivosti, je metoda HPLC-MS nejpoužívanější metodou. Metody 
využívající UV nebo fluorescenční detekci byly studovány jako alternativa 
k HPLC-MS. 
 
Kolony Hichrom Lichrosorb RP 18, 250 x 4.6 mm i. d. a Chromolith Performance 
RP 18e, 100 x 4.6 mm i.d. byly užívány při analýze s UV detekcí. Použita byla mobilní 
fáze ACN: 0.05M KH2PO4 (pH 7.5) 30:70 (v/v), UV detekce probíhala při 215 nm. 
Metoda využívající derivatizaci pomocí FMOC-Cl byla studována. Analýza byla 
prováděna na koloně Chromolith Performance RP 18e, 100 x 4.6 mm i. d, fluorescenční 
detektor byl nastaven na excitační vlnovou délku 286 nm, emisní vlnová délka byla 
315 nm. 
 
Metoda ke stanovení tetracyklinů s UV detekcí používala gradientovou eluci ACN 
a 0.02M kyseliny šťavelové. Analýza probíhala na koloně Hichrom Lichrosorb RP 8, 
250 x 4.6 mm i. d., detekce při 360 nm. 
 
Všechny studované metody nevykazovaly citlivost dostatečnou ke stanovení antibiotik 
v odpadních vodách. 
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ABBREVIATIONS 
AZI   Azithromycin  
CLA   Clarithromycin 
DOX   Doxycycline 
ERY   Erythromycin 
FD   Fluorescence detection 
FMOC-Cl  9-fluorenylmethyl-oxycarbonyl chloride 
HPLC    High performance liquid chromatography 
MIN   Minocycline 
MLs   Macrolides 
Ph. Boh.  Pharmacopoeia Bohemica 
Ph. Eur  European Pharmacopoeia 
ROX   Roxithromycin 
RP   Rveverse phased 
SPE   Solid phase extraction 
TCs   Tetracyclines 
TET   Tetracycline 
USP   United States Pharmacopoeia 
UV   Ultra violet 
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1 INTRODUCTION 
Pharmaceuticals have become recognised as relevant environmental contaminants 
in the course of the last decade.[5] 
Tons of pharmacology active substances including antibiotics are used annually 
in human medicine for diagnosis, treatment and prevention of illness. Among these 
purposes they are used in veterinary production as growth promotors. Their annual 
consumption ranges between a few kilograms and several hundred tonnes per individual 
compounds. Some of these substances are excreted unmetabolized or as active 
metabolites and can enter the environment. The amnount of pharmaceuticals and their 
bioactive metabolites being introduced to environment is probably low. However, their 
continual input into the environment may lead to a high, long-term concentration. [1] 
A large variety of different compounds has been identified in the enviroment. Both 
human and veterinary drugs were found in various environmental samples, 
e. g. sewage[2], river water[2], ground water[3], sea water[4]. Those compounds, 
depending on hydrophility, can enter the aquatic environment or remain adsorbed 
on solid particles. Some of these were detected frequently and have widespread 
distibution., the environmental persistence of some commonly prescribed drug is longer 
than a year.[1] 
The most important ways that drugs are introduced into the environment are through 
waste effuents of manufacturing processes, excreta, disposal of unused or expired drug 
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products, and accidental spills during manufacturing or distribution. Among these, 
animal excreta are the major source of environmental contamination by drugs, as most 
of the drugs used in veterinary medicine end up in manure.  
The manure and slurry (urine and faeces) are either stored or immediately applied 
to agricultural fields as fertilizers. When this manure is dispersed on the field, 
the unmetabolized drugs present in the manure or their biologically active metabolites, 
may threaten the groundwater, depending on their mobility in the soil system, and affect 
terrestrial and aquatic organisms as a result of leaching from fields. The same situation 
is found when sludge from sewage-treatment plants is used to fertilize soils.  
Drugs used by humans are discharged into sewers together with urine and faeces 
and then enter sewage-treatment plants.  
The controlled application of sludge to soils presents clear benefits, since it results 
in the recycling of organic matter and nutrients. However, if the sludge contains 
pollutants, the application of sludge directly adds undesirable substances to the soil 
and leads to corresponding negative effects.[1] 
Information on the physical and chemical properties,such as the octanol/water partition 
coeficient, dissociation constants, vapor pressure or Henry’s Law constant of a drug, 
may help determine whether a compound is likely to concentrate in the aquatic, 
terrestrial, or atmospheric environment. By simply following the disappearance 
of a substance, one cannot conclude that it was destroyed; it may exist in another state 
or form. However, identifying metabolic products is difficult because of both the great 
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number of metabolites or degradation products potentially generated by one parent 
compound and the high cost or the lack of standards.[1] 
 
Figure 1 Principal routes of environmental exposure to drugs consumed in human 
and veterinary medicine. 
The possible fate of drugs in the sewage treatment plant as for all other xenobiotics may 
be divided as follows: 
a) The drugs or metabolites of the parent drug are mineralised 
by microorganisms to carbon dioxide and water. 
b) The drugs or metabolites of parent drug is more or less persistent 
in the sewage treatment plant, which implies that depending on the lipophylic properties 
or other binding possibilities e.g. ionic bindings, a part of the substance will be retained 
in the sludge. If the sludge is used as soil conditioner drug may be dispersed 
on agricultural fields. Again the fate of the drug depends on the lipophylic properties 
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or other ability of binding to sludge or soil. Drugs that are mobile in the soil may be 
treating to the ground water or leach to a nearby stream. Depending on the ability 
of the drug to bind solids either organisms in the terrestrial ecosystem or aquatic 
ecosystem may be exposed. 
c) The drug or metabolite of parent drug is persistent and at the same time very 
polar and nonbinding to solids. The substance will thus not be retained neither degraded 
in the sewage tratment plant and therefore easily reach the aquatic environment, 
and may affect the aquatic organisms. [5] 
An unknown portion of drugs marketed for human treatment ends in the sewer system 
as surplus medical substances. After entering the sewage treatment plant the fate 
of these drugs will be almost identical with the excreted drugs. The only difference is 
that the waste water will not include the drug metabolites often produced by humans 
before excretion. [6] 
Medical drugs are developed with the intention of performing a biological activity; they 
are therefore important as environmental pollutants in terms of their effects and their 
fate. 
The concentration of residues in surface waters are generally in low ng/ml range and do 
not necessarily represent a serious threat to drinking water quality. Unfortunately, 
the consequences of continuous presence of low concentrations of pharmaceuticals for 
the ecosystem are still not fully known. 
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The contact of hospital pollutants with aquatic ecosystems leads to a risk on biological 
balance of natural environment. Results of toxicity studies have revealed the important 
toxic activities of hospital wastewater on aquatic organisms.[7] 
Antibacterial resistance is a threat to the efficacy of antibacterial substances. Since it is 
generally agreed that the extent of usage of antibacterial substances is closely related 
to the development of antibacterial resistance, it is important to investigate this feature. 
The development of resistance to antimicrobial agents by many bacterial pathogens has 
compromised traditional therapeutic regimens, making treatment of infections more 
difficult. Three factors have contributed to the development and spread of resistance: 
mutation in common genes that extend their spectrum of resistance, transfer 
of resistance genes among diverse micro-organisms, and increases in selective pressures 
that enhance the development of resistant organisms [5].  
At the beginning of the eighties the idea to make environmental risk assessment (ERA) 
for toxic substances was launched and it became compulsory for all new chemicals sold 
in EU from 1984. General principles and guidelines for ERA of new and existing 
chemicals have been introduced by European Medicines Evaluation Agency (EMEA) 
and the Food and Drug Administration (FDA), employing similar system. Both are 
based in the comparison between the predicted environmenatal concentrations (PEC) 
and the worst-case predicted no effect concentrations (PNEC) estimated from standart 
toxicity assays. [8, 9]. 
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One of the major limitations in the analysis of contaminats (including antibiotics) 
remains the lack of methods for quantification of low concentration. For prerequisite for 
proper risk assessment and monitoring of the quality of waste, surface and drinking 
waters is the availibility of multiresidual methods that permit measurement at the low 
ng/ml level. Today analytical methodology for different groups of contaminants is being 
developed and increasing number of method is reported in the literature. Still analysis 
of this group of contaminants requires further improvement, especially for very 
complex matrices, such as wastewaters.[10] 
The aim of the study is to develop methods to quantify selected antibiotics in water 
samples by HPLC using ultraviolet and fluorescence detection. 
Macrolide and tetracycline antibiotics were choosen for this study, because of their use 
in human and veterinary medicine, their presence in environment and their possible 
effects on environment and human health. 
Various conditions will be used to achieve optimal results. 
The optimal method found will be validated and used to quantify the antibiotics 
in hospital wastewaters from 4 hospitals in Coimbra and influent and effluent 
of WWTP.  
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2 THEORETICAL PART 
2.1 Macrolides 
The macrolides are large group of  antibacterials mainly derived from Streptomyces 
spp.. Their properties are very similar and in general they have low toxicity and 
a similar spectrum of antimicrobial activity with cross-resistance between individual 
members of  the group.[11] 
The mechanism of action of the macrolides is inhibition of bacterial protein synthesis 
by binding reversibly to subunit 50S of bacterial ribosome, thereby inhibition 
of tranlocation of peptidyl tRNA . This action is maily bacteriostatic, but can be also 
bactericidal in higher concentrations. Macrolides tend to accumulate within leukocytes, 
and are therofore transported into the site of infection.[12] 
Their antimicrobial spectrum is similar to that of benzylpenicillin, but they are also 
active against such organisms as Legionella pneumoniae, Mycoplasma pneumoniae, and 
some rickettsias, chlamydias and chlamydophilas. Macrolides are an important 
alternative for patients sensitive or allergic to penicillin. Erythromycin was discovered 
in 1952 and is the macrolide used most widely. More recently developed macrolides 
include azithromycin, clarithromycin, dirithromycin, and roxithromycin. These drugs all 
appear to have similar properties to erythromycin although they may differ in their 
pharmacokinetics [13]. 
The most commonly used MLs consist of a macrocyclic lactone ring containing 14, 15, 
or 16 atoms with sugars linked via glycosidic bonds[11]. MLs contain a basic 
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dimethylamine [-N(CH3)2] group, which is able to gain a proton, so, according to their 
chemical structure, MLs have one pKa, value around 9. [14] 
Erythromycin and azithromycin have their monographs in USP, Ph. Eur., Ph. Boh, 
roxithromycin in Ph Eur., Ph  Boh.[15, 16, 17] 
2.1.1 Erythromycin 
 
 
Erythromycin is a mixture of macrolide antibiotics produced by a strain 
of Streptomyces erythreus, the main component being (3R, 4S, 5S ,6R, 7R, 9R, 11R, 
12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-O-α-L-ribo-hexopyranosyl)oxy]-14-
ethyl-7, 12, 13, trihydroxy-3, 5, 7, 9, 11, 13, hexamethyl-6-[(3, 4, 6, trideoxy-3-
dimethylamino-β-D-xylo-hexopyranosyl)-oxy]oxacyclotetradecane-2,  10-dione 
(erythromycin A).It is white or slightly yellow powder or colourless or slightly yellow 
crystals, slightly hygroscopic, slightly soluble in water (the solubility decreases 
as the temperature rises), freely soluble in ethanol, soluble in methanol.[17] 
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Erythromycin is easily inactivated by gastric acids; therefore, all orally-administered 
formulations are given either as enteric-coated or more stable salts or esters such 
as erythromycin ethylsuccinate. Most of erythromycin is decomposed in liver. Its main 
elimination is in the bile and a small portion in the urine.[18]  
2.1.2 Azithromycin 
 
 
(2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-13-[(2, 6-Dideoxy-3-C-methyl-3-O-
methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3, 4, 10-trihydroxy-3, 5, 6, 8, 10, 12, 14-
heptamethyl-11-[[3, 4, 6-trideoxy-3-(trimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-
oxa-6-azacyclopentadecan-15-one. 
It is white or almost white powder, practically insoluble in water, freely soluble 
in ethanol in methylene chloride.[17] 
Azithromycin is derived from erythromycin; however it differs in that 
a methyl-substituted nitrogen atom is incorporated into the lactone ring, thus making it 
15-membered. 
Unlike erythromycin, azithromycin is stable is acid-stable and can be taken orally with 
no need of acid protection. Its half life allows a large single dose to be administered. 
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Biliary excretion of azithromycin, predominantly unchanged, is a major route 
of elimination. Approximately 6% of the drug is ieliminated as unchanged in urine.[19] 
2.1.3 Roxithromycin 
 
 
(3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-
methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7, 12, 13-trihydroxy-10-[(E)-[(2-
methoxyethoxy)methoxy]imino]-3, 5, 7, 9, 11, 13, hexamethyl-6-[[3, 4, 6-trideoxy-3-
(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecan-2-one 
It is white, crystalline powder, very slightly soluble in water, freely soluble in acetone, 
in alcohol and in methylene chloride, slightly soluble in dilute hydrochloric acid.[17] 
Roxithromycin is derived from erythromycin, containig the same 14-membered lactone 
ring. However an N-oxime side chain is attached to the lactone ring. 
Only a small portion of roxithromycin is metabolised. Most is secreted unchanged into 
the bile and some in expired air. Under 10% is secreted into the urine.[20] 
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2.2 Analysis of macrolides 
Traditionally, the analyses of of macrolides were carried out by microbiological assays 
but these methods often lack the specificity and/or sensitivity required for analytical 
purposes. Chemical analysis such as HPLC have therefore become the preferred 
technique for attempting to determine this family of antibiotics at low concetration 
levels.[21] 
Quantitative analysis has been succesfully performed in a variety of matrices (raw 
material, pharmaceutical dosage forms, biological fluids and various tissues) using 
various forms of detection. [1]. 
However no papers describing analyses of wastewaters samples using UV or 
fluorescence detection were found. 
Erythromycin has a low molar absorptivity as it lacks a suitable chromophore. Thus, 
specific, selective and sensitive UV detection of this compund is difficult. To overcome 
this problem low UV wavelenghts, where the substantial UV absorption occurs, have 
been used. Generally a wavelenght of 215 nm has proved to be the most useful. The 
same wavelenghts was used to detect both azithromycin and roxithromycin. 
Various columns were used to analyse erythromycin and its related compounds: 
reversed phase C8 and C18, reversed phase silanol-deactivated, PS-DVB. The mostly 
used mobile phases consisted of acetonitrile or methanol as organic solvents, buffer 
(phosphate, ammonium phosphate, acetate, ammonium acetate) of pH 6.5 and water in 
various proportions. An elevated separation temperature (70ºC) allowed shortened 
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analysis time. Addition of tetrabutylammonium allows a lower temperature (35ºC) to be 
used, thereby conserving the lifetime of the column.[1] 
Several methods to determine macrolide antibiotics with fluorescence detection were 
published. The pre-column derivatisation by 9-fluorenylmethyl chloroformate was used 
to increase the fluorescence detection sensitivity. The methods were used to determine 
clarithromycin[22], azithromycin [23] and roxithromycin [24] and a multiresidue 
method to determine erythromycin, roxithromycin, azithromycin and clarithromycin in 
human plasma. [25] The condition are summarized in Table No.1 
Both USP and Ph. Eur. use HPLC-UV to analyse macrolides. 
However no studies using HPLC-UV or FD achieved the limit of detection in a level 
(100-200 ng/l) in which we suppose the MLs to be found in wastewaters.[26]. The 
sensitivity of MS detection id much more higher, e. g. the LOQ for erythromycin in 
study by M. José Goméz [27] was 46 ng/ml. 
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ATB 
 
Column 
 
Mobile phase 
 
Temperature 
 
 
 
22 
 
CLA 
 
phenyl (150mm x 4.6mm i.d.) 
 
0.05M phosphate buffer (pH 3.8, triethylamine 2ml/l) 
methanol 
58º 
C 
 
 
 
23 
 
AZI 
 
phenyl (150mm x 6mm i.d.) 
 
0.05M phosphate buffer (pH 5.9, triethylamine 2ml/l) 
methanol 
 
 
62ºC 
 
 
 
24 
 
ROX 
 
RP C18 (125 x 4.6mm i.d.) 
 
0.05M potassium dihydrogen phosphate (pH 7.5), 
acetonitrile 
40ºC 
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ERY, ROX, 
 CLA, AZI 
base deactivated C18, (125 x 
4.6 i.d.) 
  
0.05M potassium, dihydrogen phosphate, (pH 7.5, 
triethylamine), 
acetonitrile 
50ºC 
 
 
 
Table 1 Conditions of analysis with FD after derivatization
2
0
 
Naformátována tabulka
Naformátováno: Písmo: není Tučné
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Naformátováno: zarovnání na střed
2.3 Tetracyclines 
Tetracyclines are a group of broad-spectrum antibiotics whose general 
usefulness has been reduced with the onset of bacterial resistence. Despite this, 
they remain the treatment of choice in some specific indications[28]. 
Tetracyclines are a group of antibacterials, originally derived from certain 
Streptomyces spp.. The first tetracycline to be introduced was chlortetracycline 
in 1952, followed closely by oxytetracycline and tetracycline, a reduction 
products of chlortetracycline, which can be produced semisynthetically.The 
more recent tetracyclines namely metacycline, doxycycline, and minocycline, 
are semisynthetic derivates.[29] 
They are usually bacteriostatic at the concentration achieved in the body. They 
inhibit protein synthesis by binding reversibly to 30S ribosomal subunit. Cells 
become resistent  at least by three mechanisms: enzymatic inactivation, efflux, 
and ribosomal protection.[2827] 
Tetracyclines all have a broad spectrum of activity which includes Gram-
positive and Gram-negative bacteria, some chlamydias and chlamydophilas, 
rickettsias, mycoplasmas, spirochetae, some mycobacteria and some protozoa. 
Tetracyclines are not generally the antibacterials of choice in Gram-positive 
and Gram-negative infections, because of the emergence of resistant organisms 
and discovery of drugs with narrower antimicrobial spectra. However they 
have a place in the treatment of chlamydial infections, rickettsial infections , 
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Lyme disease, brucellosis, tularemiae, cholera, periodontal disease, and 
acne.[2928] 
Tetracyclines have similar chemical and physicochemical properties. They are 
amphoteric compounds with characteristic pH values and form crystalline 
hydrates and salts with acids and bases. Their UV spectra show strong 
absorption around 270 and 360 nm in neutral and acidic solutions. TCs are 
soluble in acids, bases, alcohols, and polar organic solvents and are extractable 
with several organic solvents such as n-butanol and ethyl acetate. Tetracyclines 
are characterised by three values of pKa. Tetracyclines contain localized 
charges across all pH values and only achieve an neutral state as zwitterions. 
Stability of TCs is poor under strong acidic or alkaline conditions and form 
reversible epimers, 4-epi-TCs, anhydro-TCs, and iso-TCs under weakly acidic 
(pH3), strongly acidic (below pH2), and alkaline conditions, respectively. TCs 
produce strong fluorescence with metal ions or under basic conditions. They 
form chelate complexes with metal ions at β-diketones (C10-C12) and 
carboxamide (C2) [30] 
The studied tetracyclines have their monographs in USP, Ph. Eur., Ph. Boh. 
[15, 16, 17] 
The structure of selected TCs is shown on Fig No. 2 
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Figure 2 Structure of selected tetracyclines 
Tetracycline  R1 = R3 =H, R2=OH 
Doxycyline    R1 = R2= H, R3 = OH 
Minocycline   R1 =-NH(CH3)2, R2= R3 = OH 
2.3.1 Tetracycline 
(4S, 4aS, 5aS, 6S, 12aS)-4-(dimethylamino)-3, 6, 10, 12, 12a-pentahydroxy-6-
methyl-1,11-dioxo-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydrotetracene-2-
carboxamide. 
It is yellow, crystalline powder. Very slightly soluble in water, soluble 
in alcohol and in methanol, sparingly soluble in acetone. It dissolves in dilute 
acid and alkaline solutions.[17]. 
Tetracycline is not metabolised an is excreted by urine and faeces.[31] 
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2.3.2 Doxycycline 
(4S, 4a,R, 5S, 5aR, 6R, 12aS)-4-(Dimethylamino)-3, 5, 10, 12, 12a-
pentahydroxy-6-methyl-1, 11-dioxo-1, 4, 4a, 5, 5a, 6, 11, 12a-
octohydrotetracene-2-carboxamide hydrochloride 
It is yellow, crystaline powder. Very slightly soluble in water and in alcohol. It 
dissolves in dilute solutions of mineral acids and in solutions of alkali 
hydroxides and carbonates.[17] 
Doxycycline is metabolised in liver and urine and faeces are its excretion 
routes.[32] 
2.3.3 Minocycline 
(4S, 4aS, 5aR, 12aS)-4, 7-Bis(dimethylamino)-3, 10, 12, 12a-tetrahydroxy-1, 
11-dioxo-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydrotetracene-2-carboxamide 
hydrochloride 
It is yellow, crystalline powder, hygroscopic. Sparingly soluble in water, 
slightly soluble in alcohol. It dissolves in solutions of alkali hydroxides 
and carbonates.[17] 
It has a broader spectra than other members of tetracyclines. Its longer half-life 
allows administration twice daily compared to four times in case 
of tetracycline. [33] 
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2.4 Analysis of tetracyclines 
They are typically separated using a RP C8 or C18  analytical column. 
Interaction of TCs with the silanols in silica packing materials significantly 
contributes to peak tailing. End-capping on RP columns, amid columns, 
polymer columns, or polystyrene-divinyl benzene columns were used 
to minimize interactions with silanole groups and metal residues. Phenyl and 
diphenyl column were used to for their selectivity for tetracycline ring system. 
Column lenghts of 250 or 150 mm were equally used.[34] 
To avoid peak tailing acidic mobile phase containing various acids were used 
(phosphoric, citric, tartaric, EDTA, oxalic) but only a mobile phase containing 
oxalic acid enabled no tailing peaks of TCs. The resolution and asymetries of 
the TC peaks depend upon the pH of the aqueous oxalic acid solution in the 
mobile phase and the optimum pH is 2.0.[3029] 
For ultraviolet absorbance determination, TCs are typically detected at 350-
365 nm. The highly sensitive detection of TCs in HPLc is by detecting 
fluorescence after degradation of TSc under alkaline conditions (using 
polystyrene-divinyl benzene column, because it is stable in alkaline conditions) 
and the formation of a metal chelate. The formation of metal chelates of TCs 
can be performed in mobile phase or as a post-column derivatization. The 
detection limits are then higher more than ten times as those of UV detection. 
Mass spectroscopy (MS) is also used as a highly sensitive detection method of 
TCs. The following methods have been applied: thermospray MS, particle 
beam MS, atmospheric pressure chemical ionization MS, electrospray MS. The 
 26 
last two mentioned methods showed over 10-fold higher detection limits, than 
UV detection.[3433] 
The amount of TCs in wastewaters measured by HPLC-MS is often below a 
level of 1μg/ml.[35] 
Both USP and Ph. Eur. use HPLC-UV to analyse TCs. 
 
2.5 Analytical procedure 
Biological environmental sample matrices are complex and often contain 
interfering elements that can mask or interfer with the compounds of interest, 
so that direct analysis may not be possible. The concentration in wich 
pharmaceuticals are generally found have made it necessary to perform initial 
stage of concentration and purification of the analytes. 
The analytical procedure usually consist of five steps : sampling, sample 
preparation, separation, detection, and data analysis. Each step is involved in 
obtaining correct results. 
The basic concept of sample preparation is to convert a real matrix into a 
sample suitable for analysis. This process changes the interactions of 
compounds with their concrete chemical environment. These interactions are 
determined by physical and chemical properties both analytes and matrices. 
All the methods used for sample preparation have the same goal: 
   to remove potential interferences 
   to increase the concentration of an analyte 
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   if necessary, to convert an analyte into a more suitable form 
   to provide a robust, reproducible method that is independent of variations in 
the sample matrix. 
Solid-phase extraction (SPE) has gradually replaced classical liquid-liquid 
extraction and become the most common sample-preparation technique in 
environmental areas. SPE offers the following advantages over LLE: 
1. higher recoveries 
2. improved selectivity, specificity, and reproducibility 
3. elimination of emulsions 
4. less organic solvent usage 
5. shorter sample preparation time 
6. easier operation and the possibility of automation 
In SPE extraction, the analytes to be extracted are partioned between a solid 
phase and a liquid phase, and these analytes must have greater affinity for the 
solid phase than for the sample matrix. Classical SPE sorbents range from 
chemically-bonded sillica with the C8 or C18 organic group among others and 
carbon or ion-exchange materials to polymeric materials, immunosorbents, 
molecularly-imprinted polymers and restricted acces materials.[36]  
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3 PRACTICAL PART 
3.1 Standards and chemicals used 
Standards of azithromycin, erythromycin and roxithromycin were purchased 
from Sigma-Aldrich, Steinheim, Germany. 
Standards of doxycycline, minocycline and tetracycline were purchased from 
Sigma-Aldrich, Steinheim, Germany. 
Methanol of HPLC grade was purchased from Panreac, Barcelona, Spain. 
Acetonitrile of HPLC grade was purchased from Carlo Erba, Italy.  
The mili-Q water was prepared at Laboratory of Bromatology, University of 
Comibra.  
All the chemicals used were of analytical grade with exception of 
triethylamine, which was in pro synthesis grade. 
3.2 Equipment 
Columns: 
Hichrom Lichrosorb RP 8, 250 x 4.6 mm i. d. (Hichrom, Reading, UK) 
Hichrom Lichrosorb RP 18, 250 x 4.6 mm i. d. (Hichrom, Reading, UK) 
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Chromolith Performance column RP 18e, 100 x 4.6 mm i. d. (Merck, 
Darmstadt, Germany) 
302, 305 and 306 pumps (Gilson, Medical Electronics, Villiers-le-Bel, France) 
UV/VIS detector Gilson 151 (Gilson, Medical Electronics, Villiers-le-Bel, 
France) 
Unipoint software (Gilson, Medical Electronics, Villiers-le-Bel, France) 
506 C interface (Gilson, Medical Electronics, Villiers-le-Bel, France) 
Fluorescence detector LC305 (Lab Alliance, State College, PA, USA) 
Integrator SP 4270 (Spectra Physics, San Jose, CA, USA) 
Injector model 7725 (Rheodyne, Cotati,CA, USA) with 50 μl injection loop 
Polyamide membrane filters 0.22 μm (Whatman, Dassel, Germany) 
3.3 Macrolides 
3.3.1 Fluorescence detection 
We tried to develop the method according to Sastre Torano [25]. Because of 
high retention times of studied compounds analysed with C18 column by UV 
detection, we decided to use monolitic column to achieve shorter analysis time. 
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Preparation of solutions 
Stock solutions of standards  were prepared by dissolving appropriate amount 
of standard in methanol. Working solution were prepared by diluting stock 
solutions in acetonitrile. Both stock and working solutions were stored at 4º C. 
The mobile phase was prepared by mixing 600 ml of acetonitrile with 400 ml 
of solution comprising potassium dihydrogen phosphate (0.05 mol/l water) and 
500μl of triethanolamine, adjusted to pH 7.5 with a 10% natrium hydroxide 
solution. The solution was filtered through a 0.22μm filtre and degassed. 
 
Derivatization 
A 100μl volume of a acetonitrile solution of FMOC-Cl (concentration 
2.5 mg/ml), 75μl of a 0.1 M phosphate buffer in water, adjusted to a pH of 7.5 
with a 10% natrium hydroxide solution, and 200μl of working solution were 
transfered to a 1.8 ml reaction vial. The reaction vial was incubated in 
waterbath of 40º C for 40 minutes. After derivatization, 50 μl of the solution 
was injected onto chromatographic system. Four different solutions were 
prepared. 
 ATB Concentration Volume FMOC-Cl sol. Phosphate buffer 
1 AZI 1 μg/ml 200 μl 100 μl 75 μl 
2 ERY 1 μg/ml 200 μl 100 μl 75 μl 
3 ROX 1 μg/ml 200 μl 100 μl 75 μl 
4 AZI, ERY, ROX each 1μg/ml each 70 μl 100 μl 75 μl 
Table 2 Derivatization of MLs using FMOC-CL - nazev Naformátováno: Písmo: není Tučné
Naformátováno: Písmo: není Tučné,
Angličtina (Spojené království)
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Chromatographic conditions 
The analysis was performed on monolitic column The column was set at 40 ºC. 
50 μl of the solution was injected into the system. The flow of mobile phase 
was set to 2.0 ml/min. The results were detected by fluorescence detector set at 
excitation wavelength 255 nm and emision wavelength 315 nm. 
No signal of the detector was achieved. 
3.3.2 UV detection 
Preparation of solutions 
The standard solution were prepared as described at 3. 3. 1. 
The mobile phase was prepared by mixing 300 ml of ACN with 700 ml of 
0.05 water solution of potassium dihydrogen phosphate adjusted to pH 7.5 by 
tetrabutyl ammonium hydroxide. 
50μl of the standard solution in methanol (concentrations of ERY, ROX, AZI 
was 1 mg/ml). The analysis was performed on RP C 18 column, first at flow 
1.2 ml/min, but because of long time of the analysis (aproximately 30 min), the 
flow was set up to 2 ml/min, but the time was still high (retention time of ROX 
21 min). The shape of the peaks were not good as we can see on chromatogram 
of standard solution of erythromycin with its retention 
time 11.1 min (Figure No. 31). Higher amount of ACN to achieve shorter time 
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of analysis was not possible due to precipitation of potassium dihydrogen 
phosphate in the mixture. 
 
 
Figure 3 Standard solution of ERY (RP C18, MF ACN : KH2PO4  (0.05M, pH 
7.5) 70:30 (v/v) –nazev, 
Then we tried to use monolitic column to separate MLs, the flow was set at 1.0 
ml/min. We achieved shorter time of analysis, but did not get optimal 
resolution of the peaks. The chromatogram is shown on Fig No. 4. 
 
Figure 4 Standard solution of AZI, ERY, ROX (monolitic column, MF ACN : 
KH2PO4  (0.05M, pH 7.5) 70:30 (v/v) 
Naformátováno: Písmo: není Tučné
Naformátováno: Písmo: není Tučné,
dolní index
Naformátováno: Písmo: není Tučné
Naformátováno: Písmo: není Tučné,
dolní index
Naformátováno: Písmo: není Tučné
Naformátováno: Písmo: není Tučné
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The retention time of AZI, ERY, ROX were 1.6, 2.9, 6.0 min, respectively.  
The results confirmed low sensitivity of UV detection while analysing MLs in 
low concentration. No results were obtained while injecting the standard 
solutions in 10 μg/ml range. 
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3.4 Tetracyclines 
3.4.1 Fluorescence detection 
A method to determine tetracyclines in municipal and hospital wastewaters was 
developed and validated by M. Paulo and A. Pena (Laboratory of Bromatology, 
Faculty of Pharmacy, University of Coimbra, Portugal).  
Extraction of samples 
250 ml of samples were filtrated through 0.2 μm membrane filtre, the pH was 
adjusted to 3.4 by formic acid and EDTA was added, so that its concentration 
was 0.02M. 
Then a solid phase extraction was performed on SPE HLB Oasis column with 
200 mg of polymeric absorbent. The column was conditioned by 5 ml of 
methanol, 5 ml of water and finally by formic acid buffer of pH 3.4. 
The whole volume of sample was passed through column. Then 10 ml of water 
with 5% of methanol to wash the column and was dried during 5 minutes.The 
sample was eluted by 1 ml of methanol with 1% of trifluoracetic acid. After the 
elution, the sample was filtred through 0,45 μm membrane filtre and 50 μl was 
injected to chromatographic system. 
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Derivatization solution 
The derivatization solution was prepared by dissolving 6.0 g of magnesium 
acetate, 6.1 g of boric acid and 2.5 g of potassium hydroxide. The addition was 
in this order after complete disolution of previous compound to avoid 
precipition. The pH of the solution was adjusted to 9.0 by 10% natrium 
hydroxide solution. The derivatization reagent was prepared daily. 
Preparation of standards 
The stock solutions of standards were prepared by dissolving the standard in 
methanol, so that their concentration was 1 mg/ml. They were stored at 4ºC and 
were stable for a period of 28 days. The working solution were prepared by 
diluting the stock solutions by methanol. The working solution were prepared 
daily. Both stock and working solutions were stored in brown volumetric flasks 
to avoid degradation caused by light. 
 
Chromatographic conditions 
The separation was performed on RP 8 column. The gradient elution was used 
in a flow rate of 1.0 ml/min. The mobile phase A was HPLC grade acetonitrile, 
mobile phase B was 0.02M water solution of oxalic acid.  
The gradient is described in Table No. 3 
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Time (min) 
 
Mobile phase A 
(%) 
Mobile phase B 
(%) 
0 10 90 
7 40 60 
7.5 50 50 
12.9 50 50 
13 10 90 
18 10 90 
 
Table 3 Gradient elution to determine TCs 
The post column-derivatization was used after separating TCs on the column. 
The solution was pumped in a flow of 0.5 ml/min.. 
The tetracyclines were then detected by fluorescence detector set at excitation 
and emition wavelenght of 386 nm and 500 nm, respectively. 
The retention times of minocycline, epitetracycline, tetracycline and 
doxycycline were 5.89 min, 7.63 min, 8.25 min and 10.51 min, respectively. 
The quantification limits were 15 µg/ml for minocycline, 0,5 µg/ml for 
epitetracycline, 0,5 µg/ml for tetracycline and 5 µg/ml for doxycycline. The 
chromatogram of standard solution is given on Fig. No 5. 
Figure 5 Standard solution (MIN, ETC, TC, DOX), RP C8, gradient elution 
Naformátováno: Písmo: není Tučné
Naformátováno: Písmo: není Tučné
Naformátováno: Písmo: není Tučné
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The method was used to quantify amount of tetracyclines in samples from 4 
hospital and influent and effluent from wastewater treatment plant in Coimbra 
(Portugal). 
The results measured by M. Paulo in spring of 2007  are given  in Table No. 4 
 
Table 4 TTCs in hospital wastewaters 
3.4.2 UV detection 
For analysis using UV detection we used the same chromatographic conditions 
as for analysis using FD. Instead of post column derivatisation followed by 
fluorescence detection we used UV detection immediately after separation. 
The chromatogram achieved using gradient elution decribed above (Table No. 
3) is shown on Fig. No 6. The standard solution of minocycline, tetracycline 
and doxycycline of concentration 10 μg/ml of each compound was injected. 
 Hospital 1  Hospital 2 Hospital 
3 
Hospital 
4 
WWTP 
Influent 
WWTP 
Efluent 
Minocycline 317,79 
µg/L 
531,7 
µg/L 
0 0 915,27 µg/L 95,79 
µg/L 
Epitetracycline 17,5 µg/L 0 0 6 µg/L 0 9,39 µg/L 
Tetracycline 158 µg/L 0 0 29,2 
µg/L 
0 0 
Doxicycline 0 0 0 0 0 0 
Naformátováno: není zvýrazněné
Naformátováno: Písmo: není Tučné
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Figure 6 Standard solution (MIN, TC, DOX), RP C8, gradient elution 
The retention time of minocycline is 3.63 min, we can see the peaks of 
epitetracycline and tetracycline with retention times 8.92 and 9.23 min 
respectively. We can not observe good resolution of the peak of doxycycline. 
 
The gradient was changed to adjust the doxycycline peak by increasing the 
amount of acetonitrile after minocycline´s separation. The amount of 
acetonitrile increased from 0 to 40% from time 0 to 5 min and then increased 
from 40 to 70% until 12 minutes. The chromatogram is shown on Fig. No.7 
Naformátováno: Písmo: není Tučné
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. 
Figure 7 Standard solution (MIN, TC, DOX), RP C8, gradient elution 
The shape of peak of doxycycline has improved, but now we can not observe 
separation between peaks of epitetracycline and tetracycline.  
We changed the gradient to join peaks of tetracycline and epitetracycline.try to 
put the peaks together. The amount of acetonitrile increased from 10 to 40% 
from the beginning until 5 min then to 60% until 8 min and to 80% until 11 
min. The result is shown on Fig. No 8 
…
 
Figure 8 Standard solution (MIN, TC, DOX), RP C8, gradient elution 
Naformátováno: Písmo: není Tučné
Naformátováno: zvýrazněné
Naformátováno: Písmo: není Tučné
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Even with higher amount of acetonitrile we did not achieve optimal resolution. 
The analysis was also performed with isocratic flow consiting of mobile phase 
acetonitrile:0.02M oxalic acid 20:80 (v/v), but no sufficient results were 
achieved. 
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4 RESULTS AND CONCLUSION 
In our study, we did not achieve sufficient result with analysis of macrolide 
antibiotics by HPLC-UV and HPLC-FD to analyse residues of macrolide 
antibiotics in wastewaters.  
While trying to develop a method using UV detection two types of column, 
RP C18 and monolitic column, were used. A mobile phase 
ACN : 0.05M KH2PO4 (pH 7.5 adjusted by tetrabutyl ammonium hydroxide) 
was used, the detector was set at 215 nm. The beter results were gained by 
using monolitic column (shorter time of analysis, but resolution of peaks still 
not optimal), both methods showed a lack of sensitivity, necessary to analyse 
the residues of antibiotics in low levels. 
According to the results of our study, HPLC-MS is a suitable method for 
analysing wastewaters and HPLC-UV and HPLC-FD are not an alternative, 
because of their low sensitivity. 
In our study we tried to apply a method devoloped and validated by M. Paulo 
and A. Pena to quantify tetracyclines in wastewaters by HPLC-FD. The 
gradient flow of ACN and 0.02M oxalic acid was used, the analysis was 
performed on RP C18 column. After separation the derivatization with 
magnesium ions was used, the results were detected by fluorescence detector 
set at excitation wavelength 386 nm and emison wacelength 500nm. 
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The hypothesis that UV detection is less sensitive than FD was confirmed, 
what´s more, we did not achive resolution of peaks at the same conditions 
using UV detection. 
We did not analyse the samples by HPLC-FD due to technical problems with 
equipment and therefore we can not compare the levels of tetracycline in 
hospital wastewaters during spring and autumn season. 
Our study shows that HPLC-UV does not give us the results with comparison 
to both HPL-FD and even more sensitive HPLC-MS. 
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